| # | % | |||||
|---|---|---|---|---|---|---|
| 151 | HEARTWARE INTERNATIONAL INC | 199 | 1,041,000 | 0.04% | Put | |
| 152 | VTV THERAPEUTICS INC | 160,556 | 1,047,000 | 0.04% | ||
| 153 | ALLIQUA BIOMEDICAL INC | 330,128 | 1,047,000 | 0.04% | ||
| 154 | SAGE THERAPEUTICS INC | 251 | 1,062,000 | 0.04% | Call | |
| 155 | CELLECTAR BIOSCIENCES INC | 653,712 | 1,079,000 | 0.04% | ||
| 156 | RARE ELEMENT RES LTD | 3,843,873 | 1,080,000 | 0.04% | ||
| 157 | GALENA BIOPHARMA INC | 6,832 | 1,081,000 | 0.04% | Put | |
| 158 | CHINA JO-JO DRUGSTORES INC | 614,149 | 1,118,000 | 0.05% | ||
| 159 | HALOZYME THERAPEUTICS INC | 840 | 1,128,000 | 0.05% | Put | |
| 160 | TROVAGENE INC | 200,000 | 1,138,000 | 0.05% | ||
| 161 | PROVECTUS | 1,982,137 | 1,140,000 | 0.05% | ||
| 162 | POZEN INC | 200,000 | 1,167,000 | 0.05% | ||
| 163 | ANACOR PHARMACEUTICALS INC | 100 | 1,177,000 | 0.05% | Put | |
| 164 | ANACOR PHARMACEUTICALS INC | 100 | 1,177,000 | 0.05% | Call | |
| 165 | CYCLACEL PHARMACEUTICALS INC | 2,356,091 | 1,202,000 | 0.05% | ||
| 166 | NEWLINK GENETICS CORP COM | 33,658 | 1,206,000 | 0.05% | ||
| 167 | VASCULAR SOLUTIONS | 37,296 | 1,209,000 | 0.05% | ||
| 168 | ANTHERA PHARMACEUTICALS INC | 2,000 | 1,218,000 | 0.05% | Call | |
| 169 | ENDOLOGIX INC | 100,000 | 1,226,000 | 0.05% | ||
| 170 | ANTARES PHARMA INC | 722,567 | 1,228,000 | 0.05% | ||
| 171 | PACIRA PHARMACEUTICALS INC | 31,100 | 1,278,000 | 0.05% | ||
| 172 | ABBVIE INC | 23,516 | 1,280,000 | 0.05% | ||
| 173 | ADAMAS PHARMACEUTICALS INC | 76,717 | 1,284,000 | 0.05% | ||
| 174 | RELYPSA INC | 69,980 | 1,295,000 | 0.05% | ||
| 175 | OCERA THERAPEUTICS INC | 426,544 | 1,348,000 | 0.06% | ||
| 176 | T2 BIOSYSTEMS INCORPORATED | 154,521 | 1,354,000 | 0.06% | ||
| 177 | ABEONA THERAPEUTICS INC | 340,702 | 1,380,000 | 0.06% | ||
| 178 | SORRENTO THERAPEUTICS INC COM NEW | 167,064 | 1,402,000 | 0.06% | ||
| 179 | DISCOVERY LABORATORIES INC N | 4,703,551 | 1,411,000 | 0.06% | ||
| 180 | INSMED INC | 764 | 1,419,000 | 0.06% | Put | |
| 181 | MEDICINOVA INC | 500,000 | 1,420,000 | 0.06% | ||
| 182 | DYNAVAX TECHNOLOGIES CORP | 594 | 1,458,000 | 0.06% | Put | |
| 183 | PUMA BIOTECHNOLOGY INC | 195 | 1,470,000 | 0.06% | Call | |
| 184 | SYNERGY PHARMACEUTICALS DEL | 2,785 | 1,476,000 | 0.06% | Call | |
| 185 | OCULAR THERAPEUTIX INC | 105,190 | 1,479,000 | 0.06% | ||
| 186 | TROVAGENE INC | 2,600 | 1,479,000 | 0.06% | Call | |
| 187 | ADVAXIS INC | 1,460 | 1,494,000 | 0.06% | Call | |
| 188 | DYAX CORP COM CVR | 79,613 | 1,520,000 | 0.06% | ||
| 189 | CARDICA INC | 5,281,185 | 1,521,000 | 0.06% | ||
| 190 | NEWLINK GENETICS CORP | 430 | 1,541,000 | 0.06% | Put | |
| 191 | NUVASIVE INC | 320 | 1,543,000 | 0.06% | Call | |
| 192 | ENDO INTL PLC | 224 | 1,552,000 | 0.06% | Put | |
| 193 | AMARIN CORP PLC | 8,183 | 1,579,000 | 0.07% | Call | |
| 194 | APPLIED GENETIC TECHNOL CORP | 124,000 | 1,629,000 | 0.07% | ||
| 195 | OMEROS CORP | 1,489 | 1,632,000 | 0.07% | Call | |
| 196 | MOMENTA PHARMACEUTICALS INC | 1,000 | 1,641,000 | 0.07% | Call | |
| 197 | AGIOS PHARMACEUTICALS INC | 233 | 1,645,000 | 0.07% | Call | |
| 198 | FORWARD PHARMA A/S | 70,000 | 1,649,000 | 0.07% | ||
| 199 | INFINITY PHARMACEUTICALS INC | 1,971 | 1,665,000 | 0.07% | Call | |
| 200 | NUVASIVE INC | 35,000 | 1,688,000 | 0.07% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-15-065626, filed 2015.11.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
